These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 5545786)

  • 21. The metabolism of phenylbutazone in the rat.
    Bakke OM; Draffan GH; Davies DS
    Xenobiotica; 1974 Apr; 4(4):237-54. PubMed ID: 4603132
    [No Abstract]   [Full Text] [Related]  

  • 22. Detection of phenylbutazone and oxyphenbutazone in the urine of thoroughbreds.
    Finocchio EJ; Ozog FJ; Oehme FW; Johnson JH; Osbaldiston GW
    J Am Vet Med Assoc; 1970 Feb; 156(4):454-6. PubMed ID: 5414171
    [No Abstract]   [Full Text] [Related]  

  • 23. Gas-liquid chromatography of submicrogram amounts of drugs. I. Preparation, scope and limitation of columns.
    McMartin C; Street HV
    J Chromatogr; 1966 May; 22(2):274-85. PubMed ID: 5961130
    [No Abstract]   [Full Text] [Related]  

  • 24. [Method for the determination of phenylbutazone (FB) following chromatographic separation from isopyrine hydrochloride (I) and their decomposition production].
    Gołucki Z; Kobylińska-Luczko A
    Acta Pol Pharm; 1978; 35(2):233-6. PubMed ID: 665278
    [No Abstract]   [Full Text] [Related]  

  • 25. Stability studies ofphenylbutazone and phenylbutazone--antacid oral formulations.
    Matsui F; Roberston DL; Lafontaine P; Kolasinski H; Lovering EG
    J Pharm Sci; 1978 May; 67(5):646-50. PubMed ID: 641801
    [No Abstract]   [Full Text] [Related]  

  • 26. High-performance liquid chromatographic method for determination of phenylbutazone in bovine milk with special reference to the fat content in milk.
    Martin K; Stridsberg MI; Wiese BM
    J Chromatogr; 1983 Aug; 276(1):224-9. PubMed ID: 6672018
    [No Abstract]   [Full Text] [Related]  

  • 27. Faster extraction of phenylbutazone from blood and plasma.
    Stevens HM
    Clin Chem; 1970 May; 16(5):437-40. PubMed ID: 5443770
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma and urine levels of phenylbutazone in the horse.
    Piperno E; Ellis DJ; Getty SM; Brody TM
    J Am Vet Med Assoc; 1968 Jul; 153(2):195-8. PubMed ID: 5655055
    [No Abstract]   [Full Text] [Related]  

  • 29. Drug interactions in the horse: effect of furosemide on plasma and urinary levels of phenylbutazone.
    Roberts BL; Blake JW; Tobin T
    Res Commun Chem Pathol Pharmacol; 1976 Oct; 15(2):257-65. PubMed ID: 981785
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phenylbutazone: plasma concentrations and effectiveness in patients with rheumatoid arthritis.
    Orme ML
    J Int Med Res; 1977; 5 Suppl 2():40-7. PubMed ID: 913873
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug interactions in the horse: effects of chloramphenicol, quinidine, and oxyphenbutazone on phenylbutazone metabolism.
    Tobin T; Blake JW; Valentine R
    Am J Vet Res; 1977 Jan; 38(1):123-7. PubMed ID: 835859
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A case study of illicit preparation of antirheumatic analgesic with phenylbutazone as active ingredient.
    Thuan CE; Huat LB
    Med J Malaysia; 1989 Jun; 44(2):160-6. PubMed ID: 2626126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetic studies on phenylbutazone in children.
    Gladtke E
    Farmaco Sci; 1968 Oct; 23(10):897-906. PubMed ID: 5712791
    [No Abstract]   [Full Text] [Related]  

  • 34. Simultaneous analysis of flunixin, naproxen, ethacrynic acid, indomethacin, phenylbutazone, mefenamic acid and thiosalicylic acid in plasma and urine by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Singh AK; Jang Y; Mishra U; Granley K
    J Chromatogr; 1991 Aug; 568(2):351-61. PubMed ID: 1783641
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Delayed absorption of phenylbutazone caused by desmethylimipramine in humans.
    Consolo S; Morselli PL; Zaccala M; Garattini S
    Eur J Pharmacol; 1970 May; 10(2):239-42. PubMed ID: 5446377
    [No Abstract]   [Full Text] [Related]  

  • 36. Effect of lead exposure on plasma phenylbutazone levels in rats.
    Basu N; Kulsreshtha T
    Indian J Physiol Pharmacol; 1994 Jan; 38(1):61-2. PubMed ID: 8132249
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [New drugs in the 3d edition of the Czechoslovak Pharmacopoeia and their determination. II. Chromatographic and spectrophotometric determination of ketophenylbutazone].
    Citovická N; Faith L
    Cesk Farm; 1970 May; 19(4):126-32. PubMed ID: 5448540
    [No Abstract]   [Full Text] [Related]  

  • 38. Protein binding of indomethacin: binding of indomethacin to human plasma albumin and its displacement from binding by ibuprofen, phenylbutazone and salicylate, in vitro.
    Mason RW; McQueen EG
    Pharmacology; 1974; 12(1):12-9. PubMed ID: 4419599
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of azobenzene by thin-layer chromatography in pharmaceutical preparations containing phenylbutazone.
    Santoro MI; Gremião MP; Hackmann ER; Magalhães JF
    Pharmazie; 1985 Oct; 40(10):729-30. PubMed ID: 4080790
    [No Abstract]   [Full Text] [Related]  

  • 40. Proton magnetic resonance spectroscopic method for determination of phenylbutazone and oxyphenbutazone in tablets.
    Husain S; Kifayatullah M; Rao RN
    J Assoc Off Anal Chem; 1988; 71(3):525-7. PubMed ID: 3391955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.